Version 2024
Replaced Code

2024 ICD-10-CM Diagnosis Code G37.8

Other specified demyelinating diseases of central nervous system

ICD-10-CM Code:
G37.8
ICD-10 Code for:
Oth demyelinating diseases of central nervous system
Is Billable?
Not Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:

Code Classification

  • Diseases of the nervous system
    (G00–G99)
    • Demyelinating diseases of the central nervous system
      (G35-G37)
      • Other demyelinating diseases of central nervous system
        (G37)

G37.8 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of other specified demyelinating diseases of central nervous system. The code is not specific and is NOT valid for the year 2024 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

Specific Coding Applicable to Oth demyelinating diseases of central nervous system

Non-specific codes like G37.8 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10-CM codes with a higher level of specificity when coding for oth demyelinating diseases of central nervous system:

  • Use G37.81 for Myelin oligodendrocyte glycoprotein antibody disease - BILLABLE CODE

  • Use G37.89 for Other specified demyelinating diseases of central nervous system - BILLABLE CODE

Clinical Classification

New 2024 ICD-10-CM Code

G37.8 is new to ICD-10-CM code set for the FY 2024, effective October 1, 2023. The National Center for Health Statistics (NCHS) has published an update to the ICD-10-CM diagnosis codes which became effective October 1, 2023. This is a new and revised code for the FY 2024 (October 1, 2023 - September 30, 2024).

Replaced Code

This code was replaced in the 2024 ICD-10-CM code set with the code(s) listed below. The National Center for Health Statistics (NCHS) has published an update to the ICD-10-CM diagnosis codes which became effective October 1, 2023. This code was replaced for the FY 2024 (October 1, 2023 - September 30, 2024).


  • G37.81 - Myelin oligodendrocyte glycoprotein antibody disease
  • G37.89 - Other specified demyelinating diseases of cnsl

Convert G37.8 to ICD-9-CM

  • ICD-9-CM Code: 341.8 - Cns demyelination NEC
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Code History

  • FY 2024 - Code Added, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.